Free delivery for orders over 69.99€

Check order status

Become part of a community of book lovers from all over the world and get access to a whole bunch of benefits. Create an account for free

Free delivery for purchases over 69.99 €

Speedy courier 3.99 € Speedy point 3.99 € Еконт courier 4.49 € Еконтомат/Офис на Еконт 4.49 € Ekont Box 4.49 € Sameday courier 4.49 € Sameday Box 4.49 € Box Now 4.49 €

Contact

How to shop

Help

My account

▸ Empty :-(

Free delivery for orders over 69.99€

Advances in Melanoma, An Issue of Hematology/Oncology Clinics

David E. Fisher

Language

English

Book Hardback

Libristo code: 04793863

Publishers Elsevier Health Sciences, June 2009

The field of melanoma biology has experienced a remarkable surge in recent years, owing to progress... Full description

Libristo code: 04793863

193 b

79.10 €

154.70 лв

50 % chance We search the world When will I receive my book?

Up to 30 days for returns

Customers also purchased

Operacion Terra Sara Zibrat

Paperback

28.88 € 56.48 лв

Obal se záložkou D248 Černý XL

Stationery items

32.62 € 63.80 лв

Der Häkel-Adventskalender Silke Guhlmann

Hardback

11.74 € 22.97 лв

Mille Baisers pour un garçon - version collector avec un chapitre bonus Tillie Cole

Hardback

12.72 € 24.87 лв

Der große Rock & Pop LP/CD Preiskatalog 2024/25 Fabian Leibfried

Paperback

32.72 € 64.00 лв

Historia św jana ewangelisty wielcy przyjaciele Jezusa Francesca Fabris

Paperback

2.51 € 4.91 лв

Rafa Nadal

Paperback

11.13 € 21.76 лв

Kytice Karel Jaromír Erben

Sheet

112.80 € 220.62 лв

Begegnung in der kleinen Sommerkuche am Meer Jenny Colgan

Adobe ePub DRM

4.61 € 9.02 лв

Alguien camina sobre tu tumba MARIANA ENRIQUEZ

Paperback

21.54 € 42.13 лв

The field of melanoma biology has experienced a remarkable surge in recent years, owing to progress which has ranged from the most basic laboratory/preclinical discoveries to clinical developments that have begun to transform the management and prognosis for at least certain melanoma patients. Among the key areas that have contributed to this progress are studies relating to signaling and transcriptional pathways that regulate control over differentiation and survival of the melanocyte lineage. The identification of recurring activating mutations in specific signaling factors (B-RAF, N-Ras, c-KIT), amplification of other melanoma oncogenes (MITF, NEDD9), and the crucial recognition that certain of these genomic events occur within melanomas arising with specific clinical features (eg mucosal or acral origin) have led to clear recognition that melanoma is indeed 'many different diseases'. While the various subclasses of melanoma may share common features, such as profound invasive and metastatic propensity, it is also likely that sharply focused therapeutic strategies may exploit the functionally critical molecular engines, which distinguish these subclasses. Certain strategies focus upon the immunogenicity and striking clinical opportunities afforded by immune modulation, while others focus more directly on tumor-specific targeting. This issue brings together some of the leaders who have contributed significant insights from basic melanoma biology to progress in the clinic.